Back to MW MARSHALL WACE, LLP

GPCRGPCR
Showing 8 of 12 quarters

Position history for MWMARSHALL WACE, LLP's holdings in STRUCTURE THERAPEUTICS INC

MARSHALL WACE, LLP holds 267,592 shares of GPCR (STRUCTURE THERAPEUTICS INC), worth $14.4M as of 2026-Q2. The position was increased (+287.2% shares). GPCR represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$14.4M

Current Shares

267,592

Total Value Change

+$8.5M

Total Shares Change

+134,916

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
267,592
+287.2%
$14.4M0.0%$53.67
45
2026-Q1
Decreased
69,107
-59.0%
$3.3M0.0%$63.03
0
2025-Q4
New
168,584
-
$11.7M0.0%$67.78
39
2025-Q3
Exited
0
-100.0%
$00.0%$25.30
0
2025-Q2
Increased
176,060
+474.9%
$3.7M0.0%$21.08
43
2025-Q1
Decreased
30,626
-94.8%
$530,1370.0%$19.77
0
2024-Q4
Increased
583,207
+339.6%
$15.8M0.0%$26.63
45
2024-Q3
Increased
132,676
+74.7%
$5.8M0.0%$41.75
41

Other major holders of GPCR: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used